Form 4 for ETON Eton Pharmaceuticals, Inc.
Accepted 2021-08-20 00:00:00 ET · period of report 2021-08-20 · accession 0001493152-21-020809 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-20 | 2021-08-20 | ETON | Troutman William Wilson | CFO, Treas, Sec | P - Purchase | $4.43 | +5,000 | 23.0K | +28% | +$22.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-20 | P | A | 5,000 | $4.43 | 23,027 | D | — | — |